Rossmax International

Rossmax International R&D per Employee

The R&D Spending per Employee of Rossmax International (4121.TWO) as of Nov 5, 2026 is 55,214.51 TWD. In the previous year, R&D Spending per Employee was 53,493.26 TWD — a change of 3.22% (higher).

R&D per Employee

55,214.51TWD

YoY

3.22%

Last updated:

R&D Spending per Employee of Rossmax International is 2025 55,214.51 TWD. R&D Spending per Employee of Rossmax International was 2024 53,493.26 TWD. It decreases by 3.22% higher compared to the previous year.

The Rossmax International R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
44,621.76 TWD
Jan 1, 2019
66,712.95 TWD
Jan 1, 2020
61,002.07 TWD
Jan 1, 2021
57,801.04 TWD
Jan 1, 2022
55,717.10 TWD
Jan 1, 2023
52,740.93 TWD
Jan 1, 2024
53,493.26 TWD
Jan 1, 2025
55,214.51 TWD
The Rossmax International R&D per Employee history
YEARR&D per EmployeeYoY
55,214.51TWD+3.22%
53,493.26TWD+1.43%
52,740.93TWD-5.34%
55,717.10TWD-3.61%
57,801.04TWD-5.25%
61,002.07TWD-8.56%
66,712.95TWD+49.51%
44,621.76TWD+6.05%
42,076.68TWD-11.06%
47,306.74TWD-12.34%
53,965.80TWD-8.69%
59,101.55TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Rossmax International Stock analysis

What does Rossmax International do? Rossmax International Ltd, listed on the Taiwan Stock Exchange under ticker 4121.TWO with ISIN TW0004121009, is a healthcare company headquartered in Taipei City, Taiwan. Founded through an IPO on November 28, 2002, the company employs 965 people. It operates within the healthcare sector, focusing on the design, manufacture, research, and development of healthcare products. Its primary product lines include digital sphygmomanometers, respiratory therapy products, temperature series products, and blood oxygen meters. Rossmax distributes its products both domestically within Taiwan and internationally across markets in Europe, the Americas, and other regions. The company maintains a website at https://www.rossmax.com/ for further information. Rossmax International Ltd does not disclose specific financial figures or additional details beyond its operational scope and product offerings as provided in the source material. The company's activities are centered around healthcare innovation and product development aimed at meeting consumer health needs through technological solutions. Rossmax International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Rossmax International stock

R&D Spending per Employee of Rossmax International is 55,214.51 TWD in 2025.

R&D Spending per Employee of Rossmax International changed from 53,493.26 TWD to 55,214.51 TWD, representing a 3.22% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Rossmax International since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Rossmax International historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Rossmax International

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Rossmax International